Arginine Hydrochloride Reduce Rectal Mucosal Irritation of Sodium Aescinate: Molecular Docking, Physical Properties, Anti-Hemorrhoidal Activity, Safety and Topical Gel Formulations Investigation

Di Hu, Qingliang Zeng, Huanrong Wang, Wei JiangPharmaceutics 2024 · DOI

TL;DR

This study developed a novel topical gel formulation of sodium aescinate (SA) by incorporating arginine hydrochloride (Arg·HCl) to mitigate SA's inherent rectal mucosal irritation. The optimized 1:6 SA:Arg·HCl ratio gel (F5-SA gel) demonstrated reduced irritation, enhanced anti-inflammatory and anti-hemorrhoidal activity, and excellent safety profiles in animal models, paving the way for a safer and more effective rectal delivery system.

What Problem Does This Paper Address?

Sodium aescinate (SA) is a well-established compound derived from horse chestnut, known for its potent anti-inflammatory, anti-edematous, and anti-swelling properties. It's widely used for conditions like hemorrhoids and chronic venous insufficiency. However, a significant limitation to its clinical application, particularly for rectal administration, is its inherent strong irritant potential. This irritation can lead to discomfort and poor patient compliance, especially when applied to damaged mucous membranes. The researchers aimed to overcome this by developing a rectal gel formulation that reduces SA's irritancy while preserving or even enhancing its therapeutic benefits.

Methods

The study employed a multi-faceted approach:

  • Molecular Docking: Computational modeling (AutoDock Vina) was used to predict and visualize the potential interactions between SA and Arg·HCl, hypothesizing how Arg·HCl might reduce SA's irritation.
  • Gel Formulation: Six different gel formulations (F1-F6) were prepared with varying ratios of SA to Arg·HCl (from 1:0 to 1:10), keeping SA concentration constant at 2%. Standard excipients like CMC-Na and HPMC were used to create the gel matrix.
  • In Vitro Characterization: The formulated gels underwent a battery of tests to assess their physical properties:
  • Organoleptic Evaluation: Visual assessment of color, consistency, homogeneity.
  • pH Measurement: To ensure compatibility with physiological pH.
  • Centrifugation Stability Test: To check for phase separation or instability under stress.
  • Viscosity Analysis: To determine flow properties and retention at the application site.
  • Spreadability Assessment: To evaluate ease of application.
  • In Vivo Evaluation:
    • Rectal Irritation Test: Using rabbits, the researchers assessed macroscopic and microscopic changes in rectal tissue after gel administration.
  • Anti-inflammatory Activity: Assessed using two standard models: xylene-induced ear swelling in mice and histamine-induced capillary permeability in rats.
  • Anti-Hemorrhoidal Activity: Evaluated using two models: croton oil-induced anus swelling in rats and acetic acid-induced anal ulcer in rabbits.
  • Acute Toxicity Study: Administered rectally to rabbits at a very high dose to assess general toxicity and side effects.
  • Dermal Sensitivity Study: Used the Magnussen and Kligman guinea pig maximization test to evaluate potential skin sensitization.
  • Statistical Analysis: Standard statistical methods (ANOVA, Student's t-test) were used to analyze the data.

Datasets

Not discussed in the paper. The study utilized commercially available materials and animal models for its experiments.

Key Insights and Ideas

  • Arg·HCl as an Irritation Mitigator: The core insight is that Arg·HCl effectively counteracts the rectal mucosal irritation caused by SA. This is likely due to the formation of a salt-cocrystal continuum, where Arg·HCl's amphiprotic nature and ability to form hydrogen bonds with SA's hydroxyl groups stabilize the molecule and reduce its direct interaction with the sensitive rectal lining.
  • Dose-Dependent Effect: The reduction in irritation was directly correlated with the concentration of Arg·HCl. Higher ratios of Arg·HCl to SA led to progressively less irritation.
  • Synergistic Anti-inflammatory Action: The optimized gel not only reduced irritation but also showed enhanced anti-inflammatory effects compared to SA alone, suggesting a synergistic or complementary action.
  • Promising Anti-Hemorrhoidal Efficacy: The F5-SA gel demonstrated significant efficacy in promoting the healing of anal ulcers and reducing swelling in animal models of hemorrhoids, indicating its therapeutic potential.
  • Excellent Safety Profile: The optimized gel exhibited minimal acute toxicity, even at a dose significantly exceeding the therapeutic level, and importantly, did not induce dermal sensitivity.

Key Results

  • Optimal Formulation: The SA to Arg·HCl ratio of 1:6 (F5-SA gel) was identified as optimal, significantly reducing rectal mucosal irritation.
  • Rectal Irritation: The F1 group (SA alone) showed severe mucosal shedding and hyperaemia. In contrast, F5 and F6 groups maintained intact mucosal layers with minimal to no irritation.
  • Anti-inflammatory Activity: The F5 formulation exhibited the highest inhibition rate (44.1%) in xylene-induced ear swelling in mice, outperforming the positive control (dexamethasone, 29.7%). It also showed significant inhibition of histamine-induced capillary permeability.
  • Anti-Hemorrhoidal Activity: F5-SA gel significantly reduced anal swelling in rats and promoted anal ulcer healing in rabbits, with dose-dependent effects observed.
  • Acute Toxicity: Rectal administration of F5-SA gel at 132 mg·kg⁻¹·d⁻¹ (198 times the therapeutic dose) in rabbits resulted in no mortality or significant adverse effects, except for a transient reduction in food intake on the day of administration.
  • Dermal Sensitivity: The F5-SA gel did not induce any signs of dermal sensitivity in guinea pigs, indicating its safety for topical application.
  • Physical Properties: All gels exhibited favorable pH (5.85-7.00), good stability, appropriate viscosity, and spreadability, making them suitable for rectal application.

Limitations and Future Work

  • Animal Models: While robust, the study relied on animal models. Future work should include clinical trials in humans to confirm the safety and efficacy of the F5-SA gel.
  • Mechanism of Irritation: While molecular docking provided insights into the interaction between SA and Arg·HCl, the precise mechanism of SA-induced mucosal irritation is not fully elucidated. Further research could explore this in more detail.
  • Long-term Effects: The acute toxicity and dermal sensitivity studies were conducted over relatively short periods. Long-term safety studies might be beneficial.

The authors conclude that the F5-SA gel is a promising formulation that offers a safer and more effective rectal delivery system for SA, with potential for treating hemorrhoids and other rectal conditions. Future clinical studies are recommended to validate these findings in human subjects.

Summary updated

Abstract

<b>Background/Objectives</b>: Sodium aescinate (SA) is commonly used topically due to its anti-inflammatory, anti-edematous, and anti-swelling properties. However, the clinical application of SA is limited by strong irritation, and cannot be used on the damaged skin and mucous membrane. This study aimed to investigate whether arginine hydrochloride (Arg·HCl) could reduce the rectal mucosal irritation of SA through the formation of a gel. <b>Methods</b>: Molecular docking was first used to explore potential interactions between SA and Arg·HCl. Gels for rectal administration were then formulated by combining SA with various ratios of Arg·HCl (from 1:0 to 1:10). In vitro tests, including pH, centrifuge stability, viscosity, and spreadability analysis, were conducted. The optimal gel formulation was determined based on rectal mucosal irritation tests and anti-inflammatory experiments. Additionally, the anti-hemorrhoidal characteristics and safety of the optimal gel in terms of acute toxicity and dermal sensitivity were evaluated. <b>Results</b>: The optimal SA to Arg·HCl ratio of 1:6 (F5-SA gel) was identified, significantly reducing rectal mucosal irritation while enhancing anti-inflammatory activity. The F5-SA gel demonstrated high efficacy against hemorrhoids, notably promoting anal ulcer healing. When administered rectally to rabbits at a dose of 132 mg·kg<sup>-1</sup>·d<sup>-1</sup> (198 times the recommended therapeutic dose), no other obvious side effects were observed except a significant reduction in food intake on the day of administration. In addition, the gel did not induce dermal sensitivity. <b>Conclusions</b>: The F5-SA gel is a promising formulation that can reduce irritation and toxic side effects, and enhance the therapeutic effect to some extent, ultimately achieving a safer and more effective rectal delivery system for SA.
BibTeX
@inproceedings{hu2024arginine,
  author = {Di Hu and Qingliang Zeng and Huanrong Wang and Wei Jiang},
  title = {{Arginine Hydrochloride Reduce Rectal Mucosal Irritation of Sodium Aescinate: Molecular Docking, Physical Properties, Anti-Hemorrhoidal Activity, Safety and Topical Gel Formulations Investigation}},
  booktitle = {Pharmaceutics},
  year = {2024},
  doi = {10.3390/pharmaceutics16121498},
}
Figure